MERIDIGEN

Meridigen Biotech Co., Ltd. (Meridigen) is dedicated to developing mesenchymal stem cells (MSCs)-based technologies from manufacturing, characterization, storage, to drug discoveries. Moreover, we have been acquiring other avant-garde technologies, such as machine learning and artificial intelligence, to strive toward invention of smart medical products for the improvement of innovation and precision of medicine. Meridigen's MSC drugs strictly follow the international standard of Pharmaceutical Inspection Co-operation Scheme Good Manufacturing Practice (PIC/S GMP). Whereby, we have optimized the large-scale manufacturing process, from the raw materials to the final products. It also complies with TFDA's regulations "Guideline on human cell-based medicinal products" and "Guidelines on the clinical applications of human cell-based medicinal products". Besides, the manufacturing process has many steps of tests that have been referred to the drug regulatory of FDA, MFDS (Korea), and EU, to..

Also known as: Meridigen Biotech Co., Ltd., Meridigen Biotechnology